Bidop instructions for use
- Bidop instructions for use
- Form of formulation and composition of the preparation
- Pharmacological properties of the preparation
- Indications for use
- Contraindications to use
- Dosing and Administration
- Side effects and drug overdose
- Interaction with other medicinal products
- special instructions
- Leave and storage conditions
- Bidop analogues
- Bidop price
Bidop refers to a group of beta-blockers and is prescribed to patients for the treatment of coronary heart disease and hypertension.
Form of formulation and composition of the preparation
The product of Bidop is available in the form of tablets for oral administration. The tablets are covered with a protective coat of yellowish color with small inclusions of yellow color. The main active substance of the drug is bisoprolol hemifuramate. Tablets are packed in blisters of 14 pieces, which are sold in cardboard packs.
Pharmacological properties of the preparation
When ingested, the drug is quickly absorbed through the mucous membranes of the gastrointestinal tract into the common bloodstream. Bedop tablets contribute to the normalization of the heart and vessels, reduce the signs of tachycardia and eliminate shortness of breath, normalize blood pressure indicators for hypertension.
Indications for use
Tablets Bidop is prescribed to patients for the treatment of such conditions:
- Arterial hypertension;
- Cardiac ischemia;
- Disturbance of the cardiovascular system;
- For preventive purposes with frequent attacks of angina pectoris.
Contraindications to use
According to the instructions, the drug has a number of serious contraindications, which must be carefully examined before the start of therapy. These include:
- Cardiogenic shock;
- Acute congestive heart failure;
- Collapse and other acute circulatory disorders;
- Swelling of the lung;
- Chronic heart failure in the stage of decompensation;
- Low blood pressure;
- Violation of the heart rhythm, in particular, pronounced bradycardia;
- Bronchial asthma or chronic obstructive pulmonary disease;
- Metabolic acidosis;
- Raynaud's disease;
- Age of patients under 18;
- Individual intolerance to the components of the drug.
Tablets Bidop with extreme caution are prescribed for patients with impaired functioning of the kidney or liver, thyroid gland diseases, diabetes, elderly people.
Dosing and Administration
The dosage of the drug and the duration of the course of treatment are determined by the physician for each individual patient individually. The dose of the drug depends on the diagnosis, severity of the pathological process, age, body weight, the presence of concomitant diseases and other factors.
Tablets are taken in the morning on an empty stomach, without chewing and drinking with a sufficient amount of liquid. The minimum effective daily dose of the drug is 5 mg, the maximum should not exceed 20 mg per day.
Patients with impaired renal or hepatic function should not take more than 10 mg of the drug per day, as this can lead to serious side effects and complications.
Side effects and drug overdose
If the dosage given by the doctor is observed, the side effects of the patient develop quite infrequently. With the uncontrolled use of tablets and self-increase in the daily dose, the symptoms of overdose develop rapidly in the patient, which manifest themselves as follows:
- Inhibition of respiratory function;
- A sharp drop in blood pressure;
- Cyanosis of the extremities;
- Lowering blood glucose;
- Chronic heart failure;
- Dizziness and fainting;
- Convulsions .
Treatment of an overdose is symptomatic. In these cases, the patient must be immediately taken to the clinic for gastric lavage. With the development of oppression of the cardiovascular system, the patient is administered cardiac glycosides, glucagon and diuretics. With the development of bronchospasm inhalation prescribed drugs from the group of beta2-adrenostimulyatorov.
Interaction with other medicinal products
With the simultaneous use of Bidop with allergotests or parallel testing of allergens, the patient has a dramatically increased risk of developing severe allergic skin reactions and anaphylactic shock.
The simultaneous use of this medication with iodine-containing drugs (preparations for contrasting with x-rays) increases the likelihood of side effects and allergic reactions from Bidop.
With the simultaneous use of this drug with oral hormonal contraceptive pills, the effectiveness of the latter decreases, which should be warned by patients who prefer this method of contraception.
When used in parallel with drugs that lower blood glucose levels, their effectiveness decreases, which should be taken into account in patients with diabetes mellitus.
With the simultaneous use of Bidop with Nifedipine, the patient's blood pressure may drop dramatically, leading to fainting or collapse.
Application of the drug during pregnancy and breastfeeding
In the first trimester of pregnancy, the use of the drug Bidop to future mothers is contraindicated. In medicine, there is no evidence of safety or the presence of teratogenic effects of the active ingredients on the fetus in the first 12 weeks, however, in order to prevent them, it is better not to use the medicine.
In the 2nd and 3rd trimester, treatment with the drug is only possible if the expected benefit to the mother is higher than the possible negative effects on the fetus. Gynecologists strongly recommend to refrain from taking any medications during the period of gestation.
If it is necessary to apply Bidop in the period of breastfeeding, it is necessary to transfer the baby to artificial feeding with a milk mixture.
During treatment with the drug, the doctor must monitor the blood pressure and heart rate in the patient. Once every few months, an ECG and a blood test, in particular a blood glucose level, must be performed.
For older patients, the drug is prescribed with extreme caution, while carefully monitoring the functioning of their urinary system.
Patients with existing chronic bronchial or pulmonary disease before starting therapy with the drug should definitely conduct a study to assess respiratory function.
Patients who take Bidop and smoke notice a decrease in the therapeutic effect of the drug.
Patients who wear contact lenses at the beginning of therapy with the drug may notice increased tearing, which is normal and does not require discontinuation of treatment.
Patients with thyroid disorders should take the drug with caution, without exceeding the dose prescribed by the doctor. Abrupt withdrawal of the drug may lead to an exacerbation of the clinical symptoms of thyrotoxicosis.
If it is necessary to conduct a scheduled operation, a patient for 2 days is recommended to stop taking Bidop.
Patients with severe psychiatric abnormalities, in particular long-term depression and suicidal tendencies, are categorically contraindicated with the preparation of bidop.
Treatment with this drug is carried out under constant supervision of the doctor. At the end of the course of therapy, the drug can not be abruptly abolished, since it can provoke the development of myocardial infarction or severe arrhythmias. The daily dose is reduced gradually.
During the period of treatment with the drug, it is necessary to abandon the driving of motor vehicles, since at the beginning of the course of therapy patients note slight dizziness and slowing of the reaction rate.
Leave and storage conditions
Bidop is released in pharmacies on prescription.
The drug should be stored in a dark cool place, not accessible to children. Shelf life is 3 years.
Analogues for the active ingredient: Biol, Biprol, Bisogamma, Concor, Cordinorm, Coronale, Niperten
Bidop tablets 5mg - from 130 to 188 rubles.
Bidop tablets 10mg - from 210 to 267 rubles.